CMS certification 340091
Moses H. Cone Memorial Hospital, the
1200 N Elm St, Greensboro, NC 27401
Moses H. Cone Memorial Hospital, the has a CMS overall rating of 3 out of 5 stars. 73% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. Of the 26 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 8 and worse on none. Emergency patients spend a median of 3 h 44 min in its emergency department before leaving (US median 2 h 42 min).
Every figure on this page is published by CMS; we arrange and explain it, and score nothing ourselves.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: 830 completed surveys, 19% response rate, Oct 2024 – Sep 2025.
Emergency department
How long emergency patients spent here and how some time-critical care went, from CMS's timely and effective care measures, Oct 2024 – Sep 2025. CMS classes this emergency department's patient volume as very high; busier departments tend to have longer times, so the national median for departments of the same volume is shown too. These are medians over a year of visits, not a live wait time.
| Measure | This hospital | NC | US |
|---|---|---|---|
| Median time in the emergency department before leaving Lower is better · 419 visits sampled · US median for EDs of the same volume: 3 h 21 min | 3 h 44 min | 3 h 7 min | 2 h 42 min |
| Left before being seen Lower is better · 217,435 patients | 3% | 2% | 2% |
| Stroke symptoms: brain scan read within 45 minutes Higher is better · 64 patients | 42% | 71% | 69% |
| Severe sepsis and septic shock: all recommended care given Higher is better · 742 patients | 69% | 64% | 65% |
Deaths
How many patients died within 30 days of admission, adjusted by CMS for how sick they were. Lower is better. Data from Jul 2022 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| All patients, hospital-wide 9,854 cases | Too few cases | 2.3% | 3.9% |
| Heart attack 289 cases | Too few cases | 11.9% | 11.9% |
| Heart failure 818 cases | Too few cases | 10.4% | 11.1% |
| Pneumonia 791 cases | Too few cases | 13.7% | 15.2% |
| Stroke 1,152 cases | Too few cases | 10% | 11.9% |
| COPD 222 cases | Too few cases | 10.8% | 8.6% |
| Heart bypass surgery (CABG) 114 cases | Too few cases | 2.4% | 2.4% |
Complications
How often patients had serious complications, most of them after surgery, adjusted for how sick they were. Lower is better. Data from Jul 2022 – Jun 2024.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Serious complications, combined measure | No different | 1.08 likely 0.83 – 1.33 | 1 |
| After hip or knee replacement 349 cases | Too few cases | 4.1% | 4.1% |
| Deaths after a serious but treatable surgical complication 120 cases | No different | 204.31 per 1,000 likely 162.28 per 1,000 – 246.34 per 1,000 | 173.3 per 1,000 |
| Pressure ulcers (bed sores) 10,016 cases | No different | 0.94 per 1,000 likely 0.46 per 1,000 – 1.41 per 1,000 | 0.63 per 1,000 |
| Collapsed lung caused by a procedure 11,667 cases | No different | 0.33 per 1,000 likely 0.15 per 1,000 – 0.52 per 1,000 | 0.21 per 1,000 |
| Broken bones from falls in the hospital 11,806 cases | No different | 0.35 per 1,000 likely 0.18 per 1,000 – 0.53 per 1,000 | 0.27 per 1,000 |
| Bleeding or hematoma after surgery 2,769 cases | No different | 2.21 per 1,000 likely 0.92 per 1,000 – 3.5 per 1,000 | 2.34 per 1,000 |
| Kidney injury needing dialysis after surgery 1,262 cases | No different | 1.51 per 1,000 likely 0.05 per 1,000 – 2.96 per 1,000 | 1.67 per 1,000 |
| Breathing failure after surgery 1,288 cases | No different | 10.27 per 1,000 likely 5.05 per 1,000 – 15.49 per 1,000 | 9.42 per 1,000 |
| Blood clots in the lungs or legs after surgery 3,016 cases | No different | 2.94 per 1,000 likely 1.24 per 1,000 – 4.63 per 1,000 | 3.52 per 1,000 |
| Sepsis after surgery 1,202 cases | No different | 4.45 per 1,000 likely 1.23 per 1,000 – 7.67 per 1,000 | 5.27 per 1,000 |
| Surgical wound splitting open 583 cases | No different | 2.08 per 1,000 likely 0.67 per 1,000 – 3.49 per 1,000 | 1.77 per 1,000 |
| Accidental cut or tear during abdominal surgery 2,077 cases | No different | 0.84 per 1,000 likely 0 per 1,000 – 1.71 per 1,000 | 1.06 per 1,000 |
Infections caught in the hospital
Standardized infection ratio: 1.0 means as many infections as CMS predicted for a hospital like this one. Lower is better. Data from Oct 2024 – Sep 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Bloodstream infections from central lines (CLABSI) | Better | 0.28 likely 0.11 – 0.58 | 1 |
| Urinary tract infections from catheters (CAUTI) | Better | 0.19 likely 0.07 – 0.42 | 1 |
| Surgical site infections after colon surgery | No different | 1.26 likely 0.77 – 1.95 | 1 |
| MRSA bloodstream infections | Better | 0.46 likely 0.21 – 0.88 | 1 |
| C. diff intestinal infections | Better | 0.09 likely 0.05 – 0.15 | 1 |
1 more measure had too few cases here to report.
Readmissions and return visits
How often patients had to come back to a hospital after going home. Lower is better. Data from Jul 2023 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Readmitted after a heart attack 740 cases | Too few cases | 12.8% | 14.4% |
| Readmitted after heart failure 2,467 cases | Too few cases | 20.3% | 21.3% |
| Readmitted after pneumonia 1,916 cases | Too few cases | 15.7% | 17.3% |
| Readmitted after COPD 774 cases | Too few cases | 19.1% | 20% |
| Readmitted after heart bypass surgery 223 cases | Too few cases | 10.1% | 11% |
| Readmitted after hip or knee replacement 343 cases | Too few cases | 6.2% | 5.8% |
| Days back in hospital after a heart attack 300 cases | Too few cases | -13.9 days per 100 | — |
| Days back in hospital after heart failure 909 cases | Too few cases | -25.1 days per 100 | — |
| Days back in hospital after pneumonia 801 cases | Too few cases | -12.5 days per 100 | — |
| Unplanned visits after an outpatient colonoscopy 828 cases | No different | 14.6 per 1,000 likely 11.1 per 1,000 – 19.2 per 1,000 | 13 per 1,000 |
| Hospital admissions during outpatient chemotherapy 486 cases | No different | 10.7 per 100 likely 8.7 per 100 – 12.8 per 100 | 10.7 per 100 |
| ER visits during outpatient chemotherapy 486 cases | No different | 7 per 100 likely 5.4 per 100 – 8.9 per 100 | 5.4 per 100 |
| Unplanned visits after outpatient surgery 944 cases | No different | 0.9 likely 0.7 – 1.1 | — |
1 more measure had too few cases here to report.
Clinicians registered at this address
379 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry, plus 23 residents and trainees. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.
| Specialty | Clinicians |
|---|---|
| Nurse Anesthetist, Certified Registered | 66 |
| Internal Medicine | 65 |
| Physician Assistant | 38 |
| Emergency Medicine | 36 |
| Nurse Practitioner | 23 |
| Family Medicine | 18 |
| Pharmacist | 16 |
| Pediatrics | 11 |
| Family | 10 |
| Hospitalist | 9 |
| Physical Therapist | 9 |
| Medical | 8 |
First 12 alphabetically
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $1.6M
- 2020 $2.2M
- 2021 $1.3M
- 2022 $1.8M
- 2023 $1.3M
- 2024 $1.2M
- 2025 $808,955
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Speaking, teaching and other services | $50,775 | 34 |
| Medical devices and supplies on long-term loan | $28,044 | 19 |
| Space rental and facility fees | $12,595 | 7 |
| Debt forgiveness | $111 | 1 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Edwards Lifesciences Corporation | $156,826 | 8 |
| Amgen Inc. | $144,506 | 4 |
| Ionis Pharmaceuticals, Inc. | $102,798 | 10 |
| Medtronic, Inc. | $101,797 | 13 |
| Gilead Sciences, Inc. | $52,142 | 20 |
| Insulet Corporation | $48,975 | 29 |
| Janssen Research & Development, LLC | $43,493 | 11 |
| Abbott Laboratories | $34,416 | 24 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing the Impact of Olpasiran on Major Cardiovascular Events in Participants Wi… Amgen Inc. | $119,977 |
| The PROGRESS Trial – Continued Access 2021-01-CAP Edwards Lifesciences Corporation | $112,816 |
| IS354CS9 Ionis Pharmaceuticals, Inc. | $77,587 |
| Prevail Global Medtronic, Inc. | $56,927 |
| A Phase 3, Double-Blind, Multicenter, Randomized Study to Evaluate the Efficacy and Safety of Subcutaneous Twice Yearly Long-Acting Lenacapavir for H… Gilead Sciences, Inc. | $52,142 |
| ALLEVIATE-HF Medtronic, Inc. | $44,870 |
| The PROGRESS Trial 2021-01 Edwards Lifesciences Corporation | $44,010 |
| A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) Janssen Research & Development, LLC | $43,493 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about Moses H. Cone Memorial Hospital, the
Is Moses H. Cone Memorial Hospital, the a good hospital?
Moses H. Cone Memorial Hospital, the has a CMS overall rating of 3 out of 5 stars. Of the 26 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 8 and worse on none. These are hospital-wide results published by CMS; they do not rate individual doctors or departments.
Would patients recommend Moses H. Cone Memorial Hospital, the?
73% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. The figure comes from 830 completed HCAHPS surveys.
How long is the wait in the Moses H. Cone Memorial Hospital, the emergency room?
Emergency patients spend a median of 3 h 44 min in its emergency department before leaving (US median 2 h 42 min). Among US emergency departments with very high patient volume, like this one, the median is 3 h 21 min. 3% of emergency patients left before being seen (US 2%). These are medians over a year of visits, not a live wait time.
Does Moses H. Cone Memorial Hospital, the receive money from drug and device companies?
Drug and device makers reported $808,955 in payments to Moses H. Cone Memorial Hospital, the for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.